Saturday, December 27, 2025

In Detail Full day, Saturday, December 27, 2025, Timezone: America/Chicago

HHS targets information-blocking, certification cuts in new rule

Naomi Diaz / beckershospitalreview - The U.S. Department of Health and Human Services on Dec. 22 proposed a rule that would significantly reduce federal health IT certification requirements, revise information-blocking policies and establish a framework to support AI-enabled interoperability…

AI Summary: The U.S. Department of Health and Human Services has proposed a sweeping new rule aimed at slashing nearly 34 of the existing 60 health IT certification requirements. The move is designed to curb information blocking and reduce administrative burdens, signaling a major policy shift for healthcare technology.

AstraZeneca bets up to $2B on Jacobio’s pan-KRAS inhibitor for cancer

Ayisha Sharma / endpoints - AstraZeneca is spending $100 million upfront to secure ex-China rights for an early-stage cancer drug developed by Jacobio Pharma. The UK drugmaker will be responsible for advancing and selling the oral pan-KRAS inhibitor, JAB-23E73, in ...

AI Summary: Reports indicate that AstraZeneca has struck a global licensing agreement with Jacobio Pharma for its investigational pan‑KRAS inhibitor. With a deal value of up to $2 billion and an upfront commitment, the move is set to reinforce AstraZeneca’s oncology pipeline with next‑generation targeted therapy.